ArticleCellular immunology2011

Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.

Dan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.